Core Insights - The conference focused on advancements in blood pressure monitoring, particularly highlighting the wearable wrist-based blood pressure measurement technology, with Huawei's WATCH D2 gaining significant recognition for its capabilities [2][3]. Industry Developments - Dynamic blood pressure monitoring (ABPM) is emerging as a new direction in the industry, crucial for early detection and effective management of hypertension, which is closely linked to cardiovascular diseases [3]. - Traditional monitoring methods are often difficult to popularize due to stringent conditions, while wrist-based dynamic blood pressure monitors can enhance user compliance due to their accuracy and comfort [3]. Company Innovations - Huawei aims to revolutionize blood pressure management through innovative technology, collaborating with professional institutions to provide precise and convenient health management solutions [5]. - The Huawei WATCH D2 features a medical-grade precision measurement capability, offering a new approach to blood pressure management [6]. - The device incorporates an innovative sensing system with a narrow mechanical cuff, achieving accurate measurements with a width of only 26.5mm, significantly enhancing comfort and accuracy [8]. - The WATCH D2 is the first wrist-based dynamic blood pressure monitor compliant with medical standards, capable of continuous monitoring throughout the day and night [8]. - It also supports blood pressure measurement after high-intensity exercise, helping users assess exercise intensity and identify potential cardiovascular risks [12]. Future Directions - Huawei's WATCH 5 introduces a new risk screening model for hypertension without the use of a cuff, utilizing a distributed sensing system for enhanced health monitoring [13][15]. - The X-TAP smart sensing window allows users to assess average blood pressure over 24 hours and provides health reports covering multiple health metrics [15][17]. - Huawei has been deeply involved in chronic disease management for ten years, collaborating with various authoritative institutions to advance blood pressure health research [17].